399441 生物医药
已收盘 08-21 15:00:00
资讯
新帖
简况
8月21日沃森生物涨6.48%,招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 08-21 16:45
8月21日沃森生物涨6.48%,招商国证生物医药指数(LOF)C基金重仓该股
【生物医药小白投研】第二篇:医药股排雷体系
财华社 · 08-20 19:56
【生物医药小白投研】第二篇:医药股排雷体系
8月20日沃森生物创60日新高,招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 08-20 16:41
8月20日沃森生物创60日新高,招商国证生物医药指数(LOF)C基金重仓该股
ETF异动 | 易方达生物医药ETF(03186)涨近8% Moderna癌症疫苗突破引爆生物医药板块
智通财经 · 08-20 10:00
ETF异动 | 易方达生物医药ETF(03186)涨近8% Moderna癌症疫苗突破引爆生物医药板块
四大指数集体高开!生物医药板块大爆发,康希诺、沃森生物一字20CM涨停,农业、煤炭板块下跌|开盘播报
每日经济新闻 · 08-20 09:38
四大指数集体高开!生物医药板块大爆发,康希诺、沃森生物一字20CM涨停,农业、煤炭板块下跌|开盘播报
上海张江高新技术产业开发区发展“十五五”规划:增强生物医药全链条创新能力
格隆汇 · 08-19 10:26
上海张江高新技术产业开发区发展“十五五”规划:增强生物医药全链条创新能力
港股收评:恒指涨0.07% 科指跌0.9% 芯片股走弱 生物医药板块活跃
新浪港股 · 08-18
港股收评:恒指涨0.07% 科指跌0.9% 芯片股走弱 生物医药板块活跃
股市必读:浩欧博新发布《江苏浩欧博生物医药股份有限公司2026年半年度报告摘要》
证券之星 · 08-18
股市必读:浩欧博新发布《江苏浩欧博生物医药股份有限公司2026年半年度报告摘要》
“人才版图”引领 绘就生物医药千亿“产业蓝图”
经济参考报 · 08-14
“人才版图”引领 绘就生物医药千亿“产业蓝图”
资金再度关注生物医药行业,科创医药ETF华夏(588130)盘中上涨超1%
证券之星 · 08-13
资金再度关注生物医药行业,科创医药ETF华夏(588130)盘中上涨超1%
民祥生物医药被出具警示函,涉未披露年报等
蓝鲸财经 · 08-12
民祥生物医药被出具警示函,涉未披露年报等
8月11日甘李药业创60日新高,招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 08-11
8月11日甘李药业创60日新高,招商国证生物医药指数(LOF)C基金重仓该股
百余家上市公司发布2026年半年报 生物医药等行业现亮点
格隆汇 · 08-07
百余家上市公司发布2026年半年报 生物医药等行业现亮点
宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)获增资5000万元
智通财经 · 08-07
宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)获增资5000万元
天保基建:公司目前开发运营的园区主题为生物医药
证券之星 · 08-06
天保基建:公司目前开发运营的园区主题为生物医药
华金资本:重点布局集成电路、高端制造、生物医药、人工智能、新能源、新材料等国家战略性新兴产业
证券之星 · 07-29
华金资本:重点布局集成电路、高端制造、生物医药、人工智能、新能源、新材料等国家战略性新兴产业
北京艺妙神州生物医药股份有限公司IPO审核状态变更为已问询
每日经济新闻 · 07-26
北京艺妙神州生物医药股份有限公司IPO审核状态变更为已问询
上海医药(601607)披露参与设立上海上实生物医药产业私募基金暨关联交易进展,7月24日股价下跌1.27%
证券之星 · 07-24
上海医药(601607)披露参与设立上海上实生物医药产业私募基金暨关联交易进展,7月24日股价下跌1.27%
天津生物医药产业观察:9.0%增速背后的“稳”与“进
中国新闻网 · 07-24
天津生物医药产业观察:9.0%增速背后的“稳”与“进
(活力中国调研行)生态赋能科研创新 苏州厚植生物医药产业潜力
中国新闻网 · 07-24
(活力中国调研行)生态赋能科研创新 苏州厚植生物医药产业潜力
暂无数据
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2283.43,"timestamp":1787295798000,"preClose":2386.64,"halted":0,"volume":1554196984,"delay":0,"changeRate":-0.0432,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-103.21,"latestTime":"08-21 15:00:00","open":2329.18,"high":2350.72,"low":2272.78,"amount":45685000000,"amplitude":0.0327,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":5,"adr":0,"adjPreClose":2386.64,"symbolType":"index","openAndCloseTimeList":[[1787275800000,1787283000000],[1787288400000,1787295600000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441/tweets","defaultTab":"tweets","newsList":[{"id":"2661265769","title":"8月21日沃森生物涨6.48%,招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661265769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661265769?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:45","pubTimestamp":1787301939,"startTime":"0","endTime":"0","summary":"证券之星消息,8月21日沃森生物涨6.48%创60日新高,收盘报16.1元,换手率32.29%,成交量509.27万手,成交额81.79亿元。重仓沃森生物的前十大公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共14家,其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","BK0077","BK0239","BK0046","BK0070","300142","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282063","title":"【生物医药小白投研】第二篇:医药股排雷体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282063","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660282063?lang=zh_cn&edition=full","pubTime":"2026-08-20 19:56","pubTimestamp":1787226960,"startTime":"0","endTime":"0","summary":"但在高波动的创新药赛道,排雷永远优先于选股。若过去6个月内累计减持超过其持股的20%,或出现多名核心研发人员同时离职或减持,或可视为负面信号。医保常态化集采大幅降价,会直接压缩利润空间。专利到期后大量仿制药申报上市,原研产品价格承压、份额将被分流,公司业绩存在下滑风险。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-20/doc-ininynce7988458.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-20/doc-ininynce7988458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","161726","BK4588","BK1574","09939","BK4585","159938","BK1161","399441","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660066402","title":"8月20日沃森生物创60日新高,招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660066402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660066402?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:41","pubTimestamp":1787215318,"startTime":"0","endTime":"0","summary":"证券之星消息,8月20日沃森生物涨20.00%创60日新高,收盘报15.12元,换手率4.25%,成交量67.09万手,成交额10.14亿元。重仓沃森生物的前十大公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共14家,其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","161726","399441","BK0077","300142","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043472","title":"ETF异动 | 易方达生物医药ETF(03186)涨近8% Moderna癌症疫苗突破引爆生物医药板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660043472?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:00","pubTimestamp":1787191208,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,易方达生物医药ETF涨近8%,截至发稿,涨7.7%,报15.8港元,成交额264.21万港元。消息面上,因首个“mRNA个性化癌症疫苗”三期试验成功,隔夜疫苗巨头Moderna股价飙涨177%,引爆生物医药板块,纳斯达克生物科技指数大涨6.4%,创下六年来最大涨幅;今早港股多只相关概念股亦大涨超50%。公开资料显示,易方达生物医药ETF跟踪Solactive生物医药精选指数,精选港美上市生物医药公司,一站覆盖美股管线深度与中国成长红利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","BK4588","BK4585","FDN","XBI","159646","159929","161726","399441","BK4550","03186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660472123","title":"四大指数集体高开!生物医药板块大爆发,康希诺、沃森生物一字20CM涨停,农业、煤炭板块下跌|开盘播报","url":"https://stock-news.laohu8.com/highlight/detail?id=2660472123","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660472123?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:38","pubTimestamp":1787189887,"startTime":"0","endTime":"0","summary":"8月20日,A股主要指数集体高开,上证指数高开0.33%,深证成指高开1.03%,创业板指高开1.27%,科创综指高开1.35%。生物医药板块爆发,创新药、ADC、基因检测、CRO方向领涨,贵金属板块表现亮眼;农业、煤炭板块表现低迷。消息面上,昨夜美股纳斯达克生物科技指数大涨6.4%,创下六年来最大涨幅;Moderna飙升176%,市值增加440亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608203847305243.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608203847305243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0077","BK4588","BK4585","BK0239","161726","BK0046","BK0070","688185","161032","159041","300142","399441","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660791416","title":"上海张江高新技术产业开发区发展“十五五”规划:增强生物医药全链条创新能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2660791416","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660791416?lang=zh_cn&edition=full","pubTime":"2026-08-19 10:26","pubTimestamp":1787106397,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","BK4585","161726","XBI","399441","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660857468","title":"港股收评:恒指涨0.07% 科指跌0.9% 芯片股走弱 生物医药板块活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2660857468","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660857468?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:08","pubTimestamp":1787040480,"startTime":"0","endTime":"0","summary":"模拟交易客户端8月18日消息,港股三大指数涨跌不一。截至收盘,恒生指数涨0.07%,报25471.15,恒生科技指数跌0.9%,国企指数涨0.16%。猪肉股涨幅居前,牧原股份涨超4%。生物医药板块活跃,药明生物涨超4%。芯片股走弱,华虹宏力跌超7%。国金证券指出,AI正在推动半导体测试设备行业景气由传统周期修复转向结构成长。根据SEMI预测,全球半导体测试设备销售额预计于2026年同比增长31.0%至153亿美元,并于2028年达到208亿美元,2025-2028年复合增速约21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-18/doc-inintpiw0093013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","HSImain","513600","161726","07500","MHImain","KCAI","02833","399441","XBI","07200","03037","03419","83115","07300","BK4588","82800","BERZ","BK4581","03115","XSEM","09115","HHImain","MCHmain","HSI","02800","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660943163","title":"股市必读:浩欧博新发布《江苏浩欧博生物医药股份有限公司2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660943163","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660943163?lang=zh_cn&edition=full","pubTime":"2026-08-18 01:34","pubTimestamp":1786988088,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏浩欧博生物医药股份有限公司2026年半年度报告摘要截至报告期末,公司总资产为91,643.41万元,归属于上市公司股东的净资产为83,125.23万元。江苏浩欧博生物医药股份有限公司2026年度“提质增效重回报”专项行动方案的半年度评估报告2026年上半年,公司实现营业收入19,576.93万元,同比增长3.22%;归母净利润1,667.76万元,同比增长37.05%,剔除股份支付因素后净利润同比增长16.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800001789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","161726","399441","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164273","title":"“人才版图”引领 绘就生物医药千亿“产业蓝图”","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164273","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659164273?lang=zh_cn&edition=full","pubTime":"2026-08-14 03:50","pubTimestamp":1786650640,"startTime":"0","endTime":"0","summary":"研发出首个幽门螺杆菌创新药的丹诺医药成功登陆香港联交所,用于治疗胃癌的1类创新药安尼妥单抗注射液正式获批上市,精神分裂症治疗创新药凯捷乐从苏州首发销往全国……今年以来,苏州工业园区生物医药板块“捷报”频传。生物医药创新成果竞相涌现的背后,离不开引领产业发展的人才支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608143840851846.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608143840851846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","161726","BK4585","BK4581","399441","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659182609","title":"资金再度关注生物医药行业,科创医药ETF华夏(588130)盘中上涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182609","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659182609?lang=zh_cn&edition=full","pubTime":"2026-08-13 09:59","pubTimestamp":1786586368,"startTime":"0","endTime":"0","summary":"8月13日,A股市场迎来普涨行情,三大指数集体上涨。截至9:53,创业板指涨1.48%领涨两市,上证指数与深证成指分别上涨0.38%和0.79%。医药板块表现持续活跃,相关ETF产品获得关注。行情数据显示,科创医药ETF华夏盘中上涨1.41%,成交额达5665.35万元。一方面,成长与小盘风格在上周强势反弹,创业板指与科创50指数涨幅均超过6%。科创医药ETF华夏提供了低门槛一键布局科创医药板块的便捷工具,跟踪上证科创板生物医药指数,科创板涨跌幅限制20%提供高弹性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026081300009954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","588130","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974771","title":"民祥生物医药被出具警示函,涉未披露年报等","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974771","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658974771?lang=zh_cn&edition=full","pubTime":"2026-08-12 19:44","pubTimestamp":1786535098,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月12日讯,近日,天津证监局发布行政监管措施决定书,剑指天津民祥生物医药股份有限公司及相关责任人。决定书显示,民祥医药存在以下情形:未按规定披露2025年年度报告,补充披露相关人事及股东会决议公告不及时,为子公司提供担保未履行审议程序及信息披露义务。以上行为违反了《非上市公众公司监督管理办法》和《非上市公众公司信息披露管理办法》的相关规定。公司董事长刘万里、副总经理兼董秘张毅对上述违规事项负有责任。针对上述违法行为,天津证监局对民祥医药、刘万里、张毅采取出具警示函的监督管理措施,记入证券期货市场诚信档案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786526206112430419","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["161726","BK4588","399441","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658192993","title":"8月11日甘李药业创60日新高,招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658192993","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658192993?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:33","pubTimestamp":1786437227,"startTime":"0","endTime":"0","summary":"根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共30家,其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元,最新净值0.4263,较上一交易日上涨1.52%,近一年上涨0.0%。招商国证生物医药指数C的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100025962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","161726","399441","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657360664","title":"百余家上市公司发布2026年半年报 生物医药等行业现亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=2657360664","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657360664?lang=zh_cn&edition=full","pubTime":"2026-08-07 07:36","pubTimestamp":1786059397,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","BK4585","399441","161726","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661971","title":"宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)获增资5000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661971","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657661971?lang=zh_cn&edition=full","pubTime":"2026-08-07 06:57","pubTimestamp":1786057046,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宜明昂科-B 发布公告,于2026年8月6日,本公司、宜明凯尔生物医药技术(上海)有限公司、嘉兴张科领弋生科起航创业投资合伙企业、苏州新界创元企业管理合伙企业及王雪岩先生订立增资协议。根据增资协议,投资者同意以总对价人民币5000万元认缴合共人民币46.5万元经扩大注册资本,约占目标公司经扩大股权的15.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","XBI","BK4588","399441","01541","BK4585","BK4581","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657506877","title":"天保基建:公司目前开发运营的园区主题为生物医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2657506877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657506877?lang=zh_cn&edition=full","pubTime":"2026-08-06 11:36","pubTimestamp":1785987378,"startTime":"0","endTime":"0","summary":"证券之星消息,天保基建(000965)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问:近期,阳光股份等成立数字园区运营管理公司,含Ai相关业务,在市场1度引起深远影响,贵公司园区与其相比如何?有数字园区吗?相关园区含有AI业务吗?天保基建回复:您好,公司目前开发运营的园区主题为生物医药。感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600015491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0013","BK0273","BK0172","000965","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655893883","title":"华金资本:重点布局集成电路、高端制造、生物医药、人工智能、新能源、新材料等国家战略性新兴产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2655893883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655893883?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:51","pubTimestamp":1785329505,"startTime":"0","endTime":"0","summary":"证券之星消息,华金资本07月28日在投资者关系平台上答复投资者关心的问题。如何持续盈利华金资本回复:尊敬的投资者您好。公司股权投资与管理业务主要由公司下属子公司作为普通合伙人和管理人,与符合条件的有限合伙人共同成立合伙企业,以合伙企业的组织形式开展,重点布局集成电路、高端制造、生物医药、人工智能、新能源、新材料等国家战略性新兴产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900038000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000532","159703","159875","BK0075","000941.SH","159546","161037","160640","BK0103","161631","BK0200","399941","BK0059","BK0265","161726","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654223069","title":"北京艺妙神州生物医药股份有限公司IPO审核状态变更为已问询","url":"https://stock-news.laohu8.com/highlight/detail?id=2654223069","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654223069?lang=zh_cn&edition=full","pubTime":"2026-07-26 20:48","pubTimestamp":1785070080,"startTime":"0","endTime":"0","summary":"每经AI快讯,7月26日,据上交所网站,北京艺妙神州生物医药股份有限公司IPO审核状态变更为已问询。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-07-26/doc-inikcymz0261274.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-26/doc-inikcymz0261274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","BK4588","161726","KCE","BK4581","XBI","BK4127","REDS","BK4585","399441","FRHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653136038","title":"上海医药(601607)披露参与设立上海上实生物医药产业私募基金暨关联交易进展,7月24日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653136038","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653136038?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:16","pubTimestamp":1784902598,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,上海医药报收于16.38元,较前一交易日下跌1.27%,最新总市值为607.43亿元。该股当日开盘16.62元,最高16.69元,最低16.34元,成交额达1.47亿元,换手率为0.32%。近日,上海医药集团股份有限公司发布《关于参与设立上海上实生物医药产业私募基金暨关联/连交易的进展公告》。2026年7月24日,公司已签署《上海上实生物医药产业私募基金合伙企业有限合伙协议》。本次交易构成关联交易。除上述进展外,其他内容与2026年7月18日公告一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400041945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0099","BK0012","BK0184","BK0028","BK0097","BK1197","BK0020","BK0196","399441","02607","BK0183","BK0188","BK0187","601607","BK0209","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653806990","title":"天津生物医药产业观察:9.0%增速背后的“稳”与“进","url":"https://stock-news.laohu8.com/highlight/detail?id=2653806990","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653806990?lang=zh_cn&edition=full","pubTime":"2026-07-24 21:38","pubTimestamp":1784900304,"startTime":"0","endTime":"0","summary":"中新网天津7月24日电题:天津生物医药产业观察:9.0%增速背后的\"稳\"与\"进\"作者孙翼飞天津市统计局近日发布的数据显示,2026年上半年,全市医药制造业增加值同比增长9.0%,高于全国规上医药工业6.4%的增速2.6个百分点,也大幅跑赢全市规上工业4.4%的平均水平。在复杂外部环境下,这一增速引发关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607243820762939.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607243820762939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4588","399441","BK4585","BK4581","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653087051","title":"(活力中国调研行)生态赋能科研创新 苏州厚植生物医药产业潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2653087051","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653087051?lang=zh_cn&edition=full","pubTime":"2026-07-24 21:20","pubTimestamp":1784899212,"startTime":"0","endTime":"0","summary":"中新网苏州7月24日电(王昊常慕城)“4个人背着包带着技术来,短短数月便完成融资、搭建实验室,这就是我们园区的优势。”苏州工业园区生物产业发展有限公司总经理周刚这样讲述发生在苏州生物医药产业园(以下简称“BioBAY”)的创业故事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607243820730345.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607243820730345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4585","BK4581","BK4588","161726","399441"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787352775801,"stockEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":0.054},{"period":"3month","weight":0.1419},{"period":"6month","weight":0.0504},{"period":"1year","weight":-0.0548},{"period":"ytd","weight":0.0641}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0099},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0433},{"period":"1year","weight":0.0356},{"period":"ytd","weight":-0.016}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}